Renoprotective mechanisms of soy protein intake in the obese Zucker rat

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 5, 2008, Pages

  Trujillo, Joyce ^a,b   Cruz, Cristino ^a,b   Tovar, Armando ^b   Vaidya, Vishal ^c   Zambrano, Elena ^b   Bonventre, Joseph V ^c   Gamba, Gerardo ^a,b   Torres, Nimbe ^b   Bobadilla, Norma A ^a,d  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Unidad de Fisiologia Molecular   (Mexico)

Author keywords

Endothelial nitric oxide synthase phosphorylation; Nitric oxide; Oxidative stress; Short leptin receptor

Indexed keywords

CASEIN; CATALASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; KIDNEY INJURY MOLECULE 1 PROTEIN; LEPTIN RECEPTOR; MESSENGER RNA; NITRIC OXIDE; PROTEIN; SOYBEAN PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ESTRADIOL BLOOD LEVEL; KIDNEY INJURY; LIPID PEROXIDATION; MALE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DIET; PROTEIN EXPRESSION; PROTEIN INTAKE; PROTEIN URINE LEVEL; RAT; RECEPTOR UPREGULATION; RENAL PROTECTION; ZUCKER RAT;

EID: 57349154311     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90385.2008     Document Type: Article

References (50)

1. Aebi HE. Catalase. In: Methods of Enzymatic Analysis, edited by Bergmeyer HU. Weinheim, Germany: Verlag Chemie, 1983, p. 273-286.
2. Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol 294: F1-F9, 2008.
3. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76: 1191-1201, 2002.
4. Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 13: 1231-1238, 1999.
5. Bray GA. The Zucker-fatty rat: a review. Fed Proc 36: 148-153, 1977.
6. Chander PN, Gealekman O, Brodsky SV, Elitok S, Tojo A, Crabtree M, Gross SS, Goligorsky MS. Nephropathy in zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. J Am Soc Nephrol 15: 2391-2403, 2004.
7. Fanti P, Asmis R, Stephenson TJ, Sawaya BP, Franke AA. Positive effect of dietary soy in ESRD patients with systemic inflammation - correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol Dial Transplant 21: 2239-2246, 2006.
8. Feria I, Pichardo I, Juarez P, Ramirez V, Gonzalez MA, Uribe N, Garcia-Torres R, Lopez-Casillas F, Gamba G, Bobadilla NA. Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity. Kidney Int 63: 43-52, 2003.
9. Friedman M, Brandon DL. Nutritional and health benefits of soy proteins. J Agric Food Chem 49: 1069-1086, 2001.
10. Gades MD, Van Goor H, Kaysen GA, Johnson PR, Horwitz BA, Stern JS. Brief periods of hyperphagia cause renal injury in the obese Zucker rat. Kidney Int 56: 1779-1787, 1999.
11. Hall JE. The kidney, hypertension, and obesity. Hypertension 41: 625-633, 2003.
12. Han DC, Isono M, Chen S, Casaretto A, Hong SW, Wolf G, Ziyadeh FN. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression. Kidney Int 59: 1315-1323, 2001.
13. Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 12: 1211-1217, 2001.
14. Johnson PR, Stern JS, Horwitz BA, Harris RE Jr, Greene SF. Longevity in obese and lean male and female rats of the Zucker strain: prevention of hyperphagia. Am J Clin Nutr 66: 890-903, 1997.
15. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59: 1498-1509, 2001.
16. Kim H, Peterson TG, Barnes S. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. Am J Clin Nutr 68: 1418S-1425S, 1998.
17. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 71: 952-958, 1976.
18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
20. Maddox DA, Alavi FK, Silbernick EM, Zawada ET. Protective effects of a soy diet in preventing obesity-linked renal disease. Kidney Int 61: 96-104, 2002.
21. Martin DS, Breitkopf NP, Eyster KM, Williams JL. Dietary soy exerts an antihypertensive effect in spontaneously hypertensive female rats. Am J Physiol Regul Integr Comp Physiol 281: R553-R560, 2001.
22. Martin PM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103: 1860-1867, 1978.
23. Matsubara M, Hayashi N, Jing T, Titani K. Regulation of endothelial nitric oxide synthase by protein kinase C. J Biochem 133: 773-781, 2003.
24. Papapetropoulos A, Fulton D, Lin MI, Fontana J, McCabe TJ, Zoellner S, Garcia-Cardena G, Zhou Z, Gratton JP, Sessa WC. Vanadate is a potent activator of endothelial nitric-oxide synthase: evidence for the role of the serine/threonine kinase Akt and the 90-kDa heat shock protein. Mol Pharmacol 65: 407-415, 2004.
25. Pedraza-Chaverri J, Barrera D, Hernandez-Pando R, Medina-Campos ON, Cruz C, Murguia F, Juarez-Nicolas C, Correa-Rotter R, Torres N, Tovar AR. Soy protein diet ameliorates renal nitrotyrosine formation and chronic nephropathy induced by puromycin aminonucleoside. Life Sci 74: 987-999, 2004.
26. Perez-Rojas J, Blanco JA, Cruz C, Trujillo J, Vaidya VS, Uribe N, Bonventre JV, Gamba G, Bobadilla NA. Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity. Am J Physiol Renal Physiol 292: F131-F139, 2007.
27. Prozialeck WC, Vaidya VS, Liu J, Waalkes MP, Edwards JR, Lamar PC, Bernard AM, Dumont X, Bonventre JV. Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney Int 72: 985-993, 2007.
28. Sakemi T, Ikeda Y, Shimazu K. Effect of soy protein added to casein diet on the development of glomerular injury in spontaneous hypercholesterolemic male Imai rats. Am J Nephrol 22: 548-554, 2002.
29. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory, 1989.
30. Schmitz PG, O'Donnell MP, Kasiske BL, Katz SA, Keane WF. Renal injury in obese Zucker rats: glomerular hemodynamic alterations and effects of enalapril. Am J Physiol Renal Fluid Electrolyte Physiol 263: F496-F502, 1992.
31. Serradeil-Le, Gal C, Raufaste D, Brossard G, Pouzet B, Marty E, Maffrand JP, Le Fur G. Characterization and localization of leptin receptors in the rat kidney. FEBS Lett 404: 185-191, 1997.
32. Singh P, Hoffmann M, Wolk R, Shamsuzzaman AS, Somers VK. Leptin induces C-reactive protein expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol 27: e302-e307, 2007.
33. Sugimoto M, Nakayama M, Goto TM, Amano M, Komori K, Kaibuchi K. Rho-kinase phosphorylates eNOS at threonine 495 in endothelial cells. Biochem Biophys Res Commun 361: 462-467, 2007.
34. Teixeira SR, Tappenden KA, Erdman JW Jr. Altering dietary protein type and quantity reduces urinary albumin excretion without affecting plasma glucose concentrations in BKS.cg-m +Lepr db/+Lepr db (db/db) mice. J Nutr 133: 673-678, 2003.
35. Tham DM, Gardner CD, Haskell WL. Clinical review 97: potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 83: 2223-2235, 1998.
36. Tomobe K, Philbrick DJ, Ogborn MR, Takahashi H, Holub BJ. Effect of dietary soy protein and genistein on disease progression in mice with polycystic kidney disease. Am J Kidney Dis 31: 55-61, 1998.
37. Tovar AR, Murguia F, Cruz C, Hernandez-Pando R, Aguilar-Salinas CA, Pedraza-Chaverri J, Correa-Rotter R, Torres N. A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J Nutr 132: 2562-2569, 2002.
38. Tovar AR, Torre-Villalvazo I, Ochoa M, Elias AL, Ortiz V, Aguilar-Salinas CA, Torres N. Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats. J Lipid Res 46: 1823-1832, 2005.
39. Trujillo J, Ramirez V, Perez J, Torre-Villalvazo I, Torres N, Tovar AR, Munoz RM, Uribe N, Gamba G, Bobadilla NA. Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation. Am J Physiol Renal Physiol 288: F108 -F116, 2005.
40. Vaidya VS, Ramírez V, Bobadilla NA, Bonventre JV. A microfluidics based assay to measure Kidney Injury Molecule-1 (Kim-1) in the urine as a biomarker for early diagnosis of acute kidney injury (Abstract). J Am Soc Nephrol 16: 192A, 2005.
41. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 290: F517-F529, 2006.
42. Velasquez MT, Bhathena SJ. Dietary phytoestrogens: a possible role in renal disease protection. Am J Kidney Dis 37: 1056-1068, 2001.
43. Warnke RA, Kempson RL. The nephrotic syndrome in massive obesity: a study by light, immunofluorescence, and electron microscopy. Arch Pathol Lab Med 102: 431-438, 1978.
44. Wei H, Bowen R, Cai Q, Barnes S, Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208: 124-130, 1995.
45. Wesson DE, Kurtzman NA, Frommer JP. Massive obesity and nephrotic proteinuria with a normal renal biopsy. Nephron 40: 235-237, 1985.
46. White DW, Kuropatwinski KK, Devos R, Baumann H, Tartaglia LA. Leptin receptor (OB-R) signaling. Cytoplasmic domain mutational analysis and evidence for receptor homo-oligomerization. J Biol Chem 272: 4065-4071, 1997.
47. Williams AJ, Walls J. Metabolic consequences of differing protein diets in experimental renal disease. Eur J Clin Invest 17: 117-122, 1987.
48. Wolf G, Hamann A, Han DC, Helmchen U, Thaiss F, Ziyadeh FN, Stahl RA. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 56: 860-872, 1999.
49. Wolf G, Ziyadeh FN. Leptin and renal fibrosis. Contrib Nephrol 151: 175-183, 2006.
50. Zoccali C. The endothelium as a target in renal diseases. J Nephrol 20, Suppl 12: S39-S44, 2007.